The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients

Cheng He(Ministry of Natural Resources), Chen Liu(Hubei Provincial Women and Children's Hospital), Guopei Luo(Fudan University Shanghai Cancer Center), Jin Xu(Fudan University Shanghai Cancer Center), Lu Yu(Shanghai Medical College of Fudan University), Xianjun Yu(Fudan University Shanghai Cancer Center), Liang Liu(Dongyang University), Jiang Long(Shanghai Medical College of Fudan University), Kaizhou Jin(Shanghai Medical College of Fudan University), Meng Guo(Fudan University)
Pancreatology
September 17, 2016
Cited by 65


Related Papers